会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Methods for detecting lung cancer and monitoring treatment response
    • 检测肺癌的方法和监测治疗反应
    • US08728823B2
    • 2014-05-20
    • US12743042
    • 2008-11-24
    • Stephen LamJohn YeeMichael KuzykDon SinMarianne Dorthy SadarCarl Martin Tammemagi
    • Stephen LamJohn YeeMichael KuzykDon SinMarianne Dorthy SadarCarl Martin Tammemagi
    • G01N33/00G01N33/566
    • G01N33/57423G01N2800/50G01N2800/52
    • A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described.
    • 描述了一种用于检测肺癌的方法,包括检测来自患有发展为肺癌风险的受试者的生物样品中CTAP III相关生物标志物的升高水平。 此外,描述了用于预测受试者中发展肺癌的风险的方法,包括检测来自受试者的生物样品中CTAP III相关生物标志物的升高水平。 此外,描述了监测肺癌治疗成功的方法,其包括检测来自接受肺癌治疗的受试者的生物样品中的CTAP III相关生物标志物的水平,以与从受试者获得的先前水平进行比较。 多变量分析可纳入这些方法,评估年龄,性别,吸烟史,吸烟状况,吸烟家族史,教育水平,COPD,社会经济状况,体重指数和肺功能等临床或人口学危险因素。 描述了用于进行这种方法的套件。
    • 4. 发明申请
    • METHODS FOR DETECTING LUNG CANCER AND MONITORING TREATMENT RESPONSE
    • 检测肺癌和监测治疗反应的方法
    • US20100248290A1
    • 2010-09-30
    • US12743042
    • 2008-11-24
    • Stephen LamJohn YeeMichael KuzykDon SinMarianne Dorthy SadarCarl Martin Tammemagi
    • Stephen LamJohn YeeMichael KuzykDon SinMarianne Dorthy SadarCarl Martin Tammemagi
    • G01N33/68C12Q1/02
    • G01N33/57423G01N2800/50G01N2800/52
    • A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment with curative intent is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with the a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described.
    • 描述了一种用于检测肺癌的方法,包括检测来自患有发展为肺癌风险的受试者的生物样品中CTAP III相关生物标志物的升高水平。 此外,描述了用于预测受试者中发展肺癌的风险的方法,包括检测来自受试者的生物样品中CTAP III相关生物标志物的升高水平。 另外,描述了以治愈意图监测肺癌治疗成功的方法,其包括检测来自接受肺癌治疗的受试者的生物样品中的CTAP III相关生物标志物的水平,以与从受试者获得的先前水平进行比较 。 多变量分析可纳入这些方法,评估年龄,性别,吸烟史,吸烟状况,吸烟家族史,教育水平,COPD,社会经济状况,体重指数和肺功能等临床或人口学危险因素。 描述了用于进行这种方法的套件。
    • 6. 发明申请
    • Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy
    • 用于诱导鱼类抗立克次体疾病免疫的疫苗和药剂,以及相关的预防性治疗
    • US20050002946A1
    • 2005-01-06
    • US10782234
    • 2004-02-18
    • Michael KuzykJan BurianWilliam KayJulian Thornton
    • Michael KuzykJan BurianWilliam KayJulian Thornton
    • A61K39/00C07K14/29A61K39/38A61K39/02
    • C07K14/29A61K39/00A61K2039/53C07K2319/00Y02A50/403
    • The use of the 17 kDa outer surface lipoprotein (OspA) of Piscirickettsia salmonis, or its homologues, as the basis of, or part thereof, a recombinant vaccine for salmonid rickettsial septicaemia and other rickettsial diseases is disclosed. Surface antigens of the bacterial pathogen P. salmonis are characterized and an immunoreactive antigen, namely the 17 kDa outer surface lipoprotein OspA of P. salmonis, as well as the nucleic acid segment that encodes the OspA immunoreactive antigen, is identified and characterized. Diagnostic techniques including the use of hybridization probes and primers as well as the production of specific antigens and antibodies that may be used in immunization techniques for inducing immunity against P. salmonis and other rickettsial diseases are disclosed, as are the development of recombinant vaccines for SRS and other rickettsial diseases based on the 17 kDa lipoprotein OspA. Augmentation of protective immunity by the inclusion of promiscuous T lymphocyte epitopes (TCE's) in fusion protein constructs in salmonids and to the use of bacterial protein inclusion bodies as a source of the protective immunogen is also disclosed.
    • 公开了使用沙门氏菌属的17kDa外表面脂蛋白(OspA)或其同系物作为鲑鱼样立克次体败血症和其他立克次体疾病的基础或其一部分的重组疫苗。 表征细菌病原体沙门氏菌的表面抗原,并鉴定和表征免疫反应性抗原,即沙门氏菌的17kDa外表面脂蛋白OspA以及编码OspA免疫反应性抗原的核酸片段。 公开了包括使用杂交探针和引物的诊断技术以及可用于诱导针对鲑鱼和其他立克次体疾病的免疫的免疫技术中的特异性抗原和抗体的产生,以及用于SRS的重组疫苗的开发 和基于17kDa脂蛋白OspA的其他立克次体疾病。 还公开了通过在混合型T淋巴细胞表位(TCE)中包含鲑鱼中的融合蛋白构建体和使用细菌蛋白包涵体作为保护性免疫原来源来增强保护性免疫。